AbbVie to invest $380 million in new North Chicago manufacturing facilities
Investment marks continued progress against AbbVie's $100 billion commitment to U.S. R&D and capital investments, including manufacturing, over the next decade
Investment marks continued progress against AbbVie's $100 billion commitment to U.S. R&D and capital investments, including manufacturing, over the next decade
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
The alliance directly links VivaMed’s computational drug hypotheses with Syngene’s preclinical development capabilities
The approved scheme will deliver around 1 million sq ft of state-of-the-art laboratory and research space across a 12-acre site
As CRISPR and prime editing applications advance, researchers increasingly rely on longer guide RNAs to boost editing efficiency and reduce off-target effects
The facility will bring 850 high-value jobs to the region, including engineers, scientists, operations personnel, and lab technicians
The new functionality complements Parse’s existing Evercode immune products
The expanded agreement significantly widens the scope of integrated services across the entire drug development lifecycle
The researchers removed a chemical group commonly used in previous NK1R drugs and replaced it with a novel molecular scaffold
Subscribe To Our Newsletter & Stay Updated